These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 36921289

  • 1. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Peigné M, Simon V, Pigny P, Mimouni NEH, Martin C, Dewailly D, Catteau-Jonard S, Giacobini P.
    Hum Reprod; 2023 May 02; 38(5):938-950. PubMed ID: 36921289
    [Abstract] [Full Text] [Related]

  • 2. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
    Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
    [Abstract] [Full Text] [Related]

  • 3. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S.
    Hum Reprod; 2019 Dec 01; 34(12):2467-2479. PubMed ID: 31735954
    [Abstract] [Full Text] [Related]

  • 4. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P, Dulęba AJ, Kario A, Chełstowski K, Branecka-Woźniak D, Kurzawa R.
    Hum Reprod; 2019 Nov 01; 34(11):2244-2253. PubMed ID: 31725884
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 01; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 6. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S, Kohen P, Xu X, Villarroel C, Muñoz A, Godoy A, Strauss JF, Devoto L.
    Hum Reprod; 2020 Jul 01; 35(7):1655-1665. PubMed ID: 32558920
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study.
    Tzeng CR, Huang Z, Asada Y, Zhang C, Ho MT, Li RHW, Kim JH, Govindarajan M, Vuyavanich T, Sini I, Wong PS, Singh S, Lin WY, Ho NT.
    Hum Reprod; 2023 Jul 05; 38(7):1368-1378. PubMed ID: 37105234
    [Abstract] [Full Text] [Related]

  • 8. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 05; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 9. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 05; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 10. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar 05; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 12. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 13. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 14. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE.
    Hum Reprod; 2017 Apr 01; 32(4):923-936. PubMed ID: 28333238
    [Abstract] [Full Text] [Related]

  • 15. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
    Wang Z, Van Faassen M, Groen H, Cantineau AEP, Van Oers A, Van der Veen A, Hawley JM, Keevil BG, Kema IP, Hoek A.
    Hum Reprod; 2024 May 02; 39(5):1078-1088. PubMed ID: 38503490
    [Abstract] [Full Text] [Related]

  • 16. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P, Morin-Papunen LC, Bloigu A, Puukka K, Ruokonen A, Järvelin MR, Franks S, Tapanainen JS, Lashen H.
    Hum Reprod; 2014 Oct 10; 29(10):2317-25. PubMed ID: 25056088
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome.
    Jiang L, Ruan X, Li Y, Gu M, Cheng J, Wang Y, Yang Y, Xu C, Wang Z, Liu L, Mueck AO.
    Gynecol Endocrinol; 2023 Dec 10; 39(1):2206927. PubMed ID: 37141919
    [Abstract] [Full Text] [Related]

  • 18. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct 10; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 19. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y, Zhai Y, Li L, Lu Y, Su S, Liu Y, Xu Z, Xin M, Zhang Q, Cao Z.
    Front Endocrinol (Lausanne); 2022 Oct 10; 13():881740. PubMed ID: 35757414
    [Abstract] [Full Text] [Related]

  • 20. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Oct 10; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.